Dentsply Sirona, The Dental Solutions Company™, announces the acquisition of gutta-percha material technologies from Healthdent Technologies International.Healthdent – located in Palmdale, CA, USA– is market leader in this dental segment.
“Healthdent’s unique and innovative gutta-percha material technologies are an ideal addition to the Dentsply Sirona Endodontics’ portfolio and perfectly complement its range of leading nickel-titanium root canal preparation file systems”, says Bill Newell Senior Vice President, Chairside Consumables & Endodontics. “Thanks to Healthdent, we will be able to offer dentists an even more comprehensive end-to-end solution for safer, faster and accurate root canal treatments.”
Ideal addition in Endodontics
As the world’s largest and most diversified manufacturer of professional dental products and technologies, Dentsply Sirona has the goal to offer complete end-to-end solutions to its customers for better, safer and faster dental care. Dentsply Sirona Endodontics has over 120 years of expertise in the field of endodontics. It provides both endodontic specialists and generalists worldwide with products and solutions to best suit their needs in the mutual quest to preserve natural teeth. Products and services are aimed to support the clinician in facilitating predicable outcomes, and more comfortable treatments for the patient with fewer treatment steps. In addition, the company aims to empower dental professionals to resolve even the most demanding cases with the best instruments and materials.
Healthdent and Dentsply Sirona have a long history together, as Healthdent has been supplying Dentsply Sirona with gutta-percha master cones for the ProTaper Gold® and WaveOne Gold® file systems worldwide in addition to ProTaper Next® and TRUshape® file systems in North America. The formulation has been trademarked Conform Fit™.
Healthdent was established in 1996 by Dr. Nathan Li, D.D.S., a worldwide leading expert in the development and manufacturing of gutta-percha. With Healthdent Technologies, Dr. Li created a unique, patented gutta-percha formulation that enables high-precision injection molding of gutta-percha master cones which are compatible with the shapes created by multi-tapered file systems. These have consistently accurate dimensions which are considerably more accurate than conventional gutta-percha cones. The formulation also provides a lower melt temperature and ideal flow characteristics that provide better performance of the gutta-percha in warm obturation techniques.
Dentsply Sirona will continue to benefit from Dr. Li’s proven experience and thought leadership as he will continue to support Dentsply Sirona as a consultant in order to ensure a smooth transition of the business and continued innovation.
“We are delighted with the acquisition of Healthdent”, concludes Valerie Baschet, Group Vice-President Global Endodontics. “It reaffirms Dentsply Sirona’s commitment to endodontic excellence.”
ABOUT DENTSPLY SIRONA
Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with a 130-year history of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. As The Dental Solutions Company, Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better, safer and faster dentistry. Dentsply Sirona’s global headquarters is located in York, Pennsylvania, and the international headquarters is based in Salzburg, Austria. The company’s shares are listed in the United States on NASDAQ under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.
This information and any attachment thereto contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance. These forward-looking statements reflect views and assumptions regarding expectations and projections about future events and are based on currently available information or information available on the date of any document incorporated by reference. You can generally identify these forward-looking statements by the use of words such as “may,” “could,” “estimate,” “will,” “believe,” “anticipate,” “think,” “intend,” “expect,” “project,” “plan,” “target,” “forecast”, and similar words and expressions. However, these words are not the exclusive means of identifying such statements. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements and may include statements relating to future revenues, expenses, margins, profitability, net income/(loss), earnings per share and other measures of results of operations and the prospects of future growth of our business. These forward-looking statements are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict. For a discussion of such risks, uncertainties and other matters that could cause actual results to differ materially, including risks relating to, among other factors, the market for dental products and services, pricing, future sales volume of the Company’s products, the possibility of changing economic, market and competitive conditions, dependence on products, dependence on key personnel, technological developments, intense competition, market uncertainties, dependence on distributors, ability to manage growth, dependence on key suppliers, dependence on key members of management, government regulation, our ability to integrate the businesses of Dentsply Sirona, acquisitions and affiliations, readers are urged to carefully review and consider various disclosures made by the Company and Dentsply Sirona in their public filings, including in their Annual Reports on Form 10-K and in their reports on Forms 10-Q and 8-K filed with the Securities and Exchange Commission.
Readers are cautioned not to place undue reliance on such statements, which speak only as of the date hereof. Except as required by law, the Company does not assume any obligation to update any forward-looking statements contained in this document or the attachments to reflect new information or future events or developments after the date any such statement is made.